Sientra (SIEN) Misses Q3 EPS by 5c, Slight Beat on Revenues
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- US stock futures muted as oil holds near April highs ahead of Fed decision
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
- Microsoft to offer buyouts to 60,000 workers in cost-cutting move - Bloomberg
- JetBlue shares drop on creditor restructuring news amid bankruptcy filing fears
- Celestica (CLS) Tops Q3 EPS by 31c, Offers Guidance
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- CAE agrees to sell Flightscape unit to SITA for $500 million
Sientra Reports Third Quarter 2018 Financial Results
November 6, 2018 4:01 PM ESTAchieves Total Net Sales of $16.9 Million, Pro Forma Growth of 58% YoY, 72% on a GAAP Basis
Record miraDry Net Sales of $8.3 Million, Pro Forma Growth of 174% YoY, 282% on a GAAP Basis
Initiates International Expansion of Breast Implants with Health Canada Submission
SANTA BARBARA, Calif., Nov. 06, 2018 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN), a medical aesthetics company (Sientra or the Company), announced today its financial results for the third quarter ended September 30, 2018.
Jeff Nugent, Chairman and Chief... More



